Product Code: GVR-4-68038-539-7
COVID-19 Sample Collection Kits Market Growth & Trends
The global COVID-19 sample collection kits market size is expected to reach USD 1.26 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to decline at a CAGR of -18.27% from 2023 to 2030. The continuous approval of diagnostic tests for effective diagnoses of SARS-CoV-2 infection raises the demand for sample collection products, such as swabs and Viral Transport Media (VTM). In addition, a shortage of testing materials such as swabs, reagents, and others has resulted in the proliferation of new players in the space, thereby driving the market revenue.
The regulatory agencies are playing a major role as the key driving force of the market, by safeguarding the product efficiency and accelerating new approvals. For instance, in June 2021, TaqPath COVID-19 Fast PCR Combo Kit 2.0 was introduced by Thermo Fisher Scientific. The kit has an innovative assay design that identifies and diagnoses existing and new COVID-19 variations accurately. The kit has a two-hour turn - around time and includes high-frequency testing. Such developments are aimed at the comfort and convenience of patients, along with minimizing the infection risk for healthcare professionals.
Furthermore, constantly expanding global financing to boost the swab production, which is currently the need of the hour, foment organic revenue growth. Some funding agencies operating in the space are the Washington Entrepreneurial Research Evaluation and Commercialization Hub (WE-REACH), the Foundation for Innovative New Diagnostics (FIND), and the U.S. Department of Health and Human Services (HHS).
COVID-19 Sample Collection Kits Market Report Highlights
- By product, swabs captured the highest revenue share of 40.95% in 2022. The Centers for Disease Control and Prevention (CDC) and the WHO have recommended nasopharyngeal swab-based diagnostic tests as the preferred mode of testing for SARS-CoV-2 detection. The large volume and usage rate of nasopharyngeal and oropharyngeal swabs has contributed to the growth of this product in the global market
- The diagnostics application segment held the market share of use of 69.89% in 2022. A continuous increase in the number of approvals by the U.S. FDA has significantly propelled segment growth
- By the site of collection, hospitals and clinics are estimated to account for the largest revenue share of 91.99% in 2022 due to the exponential increase in the number of hospitalizations related to the coronavirus.
- The U.S. dominated the North American market in 2021 owing to the largest number of cases and tests carried out in the country. The presence of key players such as COPAN Diagnostics and Roche in the region contributes to the region's total revenue
- Key participants operating in the space, such as Thermo Fisher, Becton Dickinson, COPAN Diagnostics, and Puritan Medical Products, are constantly boosting their production and supply
- For instance, in February 2022, Becton, Dickinson, and Company partnered with ReturnSafe to incorporate its BD Veritor At-Home COVID-19 test directly into the ReturnSafe testing management system. The BD Veritor At-Home COVID-19 test allows consumers to test without a supervisor at home while providing authentic results since test results can only be viewed with a smartphone. Moreover, in May 2021, New real-time PCR kits and serological tests developed by Vircell were emerging as a possible tool to deal with new emerging variants
Table of Contents
Chapter 1. Methodology And Scope
- 1.1 Market Segmentation And Scope
- 1.1.1 Segment Definitions
- 1.1.1.1 Test Segment
- 1.1.1.2 Service Provider Segment
- 1.1.1.3 Application Segment
- 1.2 Regional Scope
- 1.3 Estimates And Forecast Timeline
- 1.4 Objectives
- 1.4.1 Objective - 1
- 1.4.2 Objective - 2
- 1.4.3 Objective - 3
- 1.5 Research Methodology
- 1.6 Information Procurement
- 1.6.1 Purchased Database
- 1.6.2 Gvr's Internal Database
- 1.6.3 Secondary Sources
- 1.6.4 Primary Research
- 1.7 Information Or Data Analysis
- 1.7.1 Data Analysis Models
- 1.8 Market Formulation & Validation
- 1.9 Model Details
- 1.9.1 Commodity Flow Analysis
- 1.10 List Of Secondary Sources
- 1.11 List Of Abbreviations
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Segmentation And Scope
- 3.2. Market Lineage Outlook
- 3.2.1. Parent Market Outlook
- 3.2.2. Related/Ancillary Market Outlook
- 3.3. Market Dynamics
- 3.3.1. Growing Business Operations By Emerging And Small-Sized Players
- 3.3.2. Rising Worldwide Incidence Of Sars-Cov-2
- 3.3.3. Active Role Of Government Bodies
- 3.3.4. Key Role Of Covid Tests In Advancing Vaccine Development
- 3.4. Market Restraint Analysis
- 3.4.1. Technical And Clinical Challenges
- 3.5. Market Opportunity Analysis
- 3.5.1. Funding Programs To Drive Developments
- 3.5.2. Shortage Of Swabs And Transport Medium
- 3.6. Covid-19 Sample Collection Kits Market - Regulatory Framework
- 3.7. Covid-19 Sample Collection Kits Market - Reimbursement Framework
- 3.8. Business Environment Analysis
- 3.8.1. Swot Analysis; By Factor (Political & Legal, Economic And Technological)
- 3.8.2. Porter's Five Forces Analysis
Chapter 4. Product Business Analysis
- 4.1. Covid-19 Sample Collection Kits Market: Product Movement Analysis
- 4.2. Swabs
- 4.2.1. Swabs Market, 2020 - 2030 (USD Million)
- 4.2.2. Nasopharyngeal (Np) Swabs
- 4.2.2.1. Nasopharyngeal (Np) Swabs Market, 2020 - 2030 (USD Million)
- 4.2.3. Oropharyngeal (Op) Swab
- 4.2.3.1. Oropharyngeal (Op) Swab Market, 2020 - 2030 (USD Million)
- 4.2.4. Others
- 4.2.4.1. Others Market, 2020 - 2030 (USD Million)
- 4.3. Viral Transport Media
- 4.3.1. Viral Transport Media Market, 2020 - 2030 (USD Million)
- 4.4. Blood Collection Kits
- 4.4.1. Blood Collection Kits Market, 2020 - 2023 (USD Million)
- 4.5. Other Consumables
- 4.5.1. Other Consumables Market, 2020 - 2023 (USD Million)
Chapter 5. Application Business Analysis
- 5.1. Covid-19 Sample Collection Kits Market: Application Type Movement Analysis
- 5.2. Diagnostics
- 5.2.1. Diagnostics Market, 2020 - 2030 (USD Million)
- 5.3. Research
- 5.3.1. Research Market, 2020 - 2030 (USD Million)
Chapter 6. Site Of Collection Business Analysis
- 6.1. Covid-19 Sample Collection Kits Market: Site Of Collection Movement Analysis
- 6.2. Hospitals And Clinics
- 6.2.1. Hospitals And Clinics Market, 2020 - 2030 (USD Million)
- 6.3. Home Test
- 6.3.1. Home Test Market, 2020 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
- 7.1. Covid-19 Sample Collection Kits Market Share By Region, 2022 & 2030
- 7.2. North America
- 7.2.1. North America Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
- 7.2.2. U.S.
- 7.2.2.1. Key Country Dynamics
- 7.2.2.2. Target Disease Prevalence
- 7.2.2.3. Competitive Scenario
- 7.2.2.4. Regulatory Framework
- 7.2.2.5. Reimbursement Scenario
- 7.2.2.6. U.S. Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
- 7.2.3. Canada
- 7.2.3.1. Key Country Dynamics
- 7.2.3.2. Target Disease Prevalence
- 7.2.3.3. Competitive Scenario
- 7.2.3.4. Regulatory Framework
- 7.2.3.5. Reimbursement Scenario
- 7.2.3.6. Canada Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
- 7.3. Europe
- 7.3.1. Europe Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
- 7.3.2. Germany
- 7.3.2.1. Key Country Dynamics
- 7.3.2.2. Target Disease Prevalence
- 7.3.2.3. Competitive Scenario
- 7.3.2.4. Regulatory Framework
- 7.3.2.5. Reimbursement Scenario
- 7.3.2.6. Germany Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
- 7.3.3. Uk
- 7.3.3.1. Key Country Dynamics
- 7.3.3.2. Target Disease Prevalence
- 7.3.3.3. Competitive Scenario
- 7.3.3.4. Regulatory Framework
- 7.3.3.5. Reimbursement Scenario
- 7.3.3.6. Uk Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
- 7.3.4. France
- 7.3.4.1. Key Country Dynamics
- 7.3.4.2. Target Disease Prevalence
- 7.3.4.3. Competitive Scenario
- 7.3.4.4. Regulatory Framework
- 7.3.4.5. Reimbursement Scenario
- 7.3.4.6. France Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
- 7.3.5. Italy
- 7.3.5.1. Key Country Dynamics
- 7.3.5.2. Target Disease Prevalence
- 7.3.5.3. Competitive Scenario
- 7.3.5.4. Regulatory Framework
- 7.3.5.5. Reimbursement Scenario
- 7.3.5.6. Italy Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
- 7.3.6. Spain
- 7.3.6.1. Key Country Dynamics
- 7.3.6.2. Target Disease Prevalence
- 7.3.6.3. Competitive Scenario
- 7.3.6.4. Regulatory Framework
- 7.3.6.5. Reimbursement Scenario
- 7.3.6.6. Spain Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
- 7.3.7. Denmark
- 7.3.7.1. Key Country Dynamics
- 7.3.7.2. Target Disease Prevalence
- 7.3.7.3. Competitive Scenario
- 7.3.7.4. Regulatory Framework
- 7.3.7.5. Reimbursement Scenario
- 7.3.7.6. Denmark Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
- 7.3.8. Sweden
- 7.3.8.1. Key Country Dynamics
- 7.3.8.2. Target Disease Prevalence
- 7.3.8.3. Competitive Scenario
- 7.3.8.4. Regulatory Framework
- 7.3.8.5. Reimbursement Scenario
- 7.3.8.6. Sweden Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
- 7.3.9. Norway
- 7.3.9.1. Key Country Dynamics
- 7.3.9.2. Target Disease Prevalence
- 7.3.9.3. Competitive Scenario
- 7.3.9.4. Regulatory Framework
- 7.3.9.5. Reimbursement Scenario
- 7.3.9.6. Norway Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
- 7.4.2. Japan
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Target Disease Prevalence
- 7.4.2.3. Competitive Scenario
- 7.4.2.4. Regulatory Framework
- 7.4.2.5. Reimbursement Scenario
- 7.4.2.6. Japan Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
- 7.4.3. China
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Target Disease Prevalence
- 7.4.3.3. Competitive Scenario
- 7.4.3.4. Regulatory Framework
- 7.4.3.5. Reimbursement Scenario
- 7.4.3.6. China Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
- 7.4.4. India
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Target Disease Prevalence
- 7.4.4.3. Competitive Scenario
- 7.4.4.4. Regulatory Framework
- 7.4.4.5. Reimbursement Scenario
- 7.4.4.6. India Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
- 7.4.5. South Korea
- 7.4.5.1. Key Country Dynamics
- 7.4.5.2. Target Disease Prevalence
- 7.4.5.3. Competitive Scenario
- 7.4.5.4. Regulatory Framework
- 7.4.5.5. Reimbursement Scenario
- 7.4.5.6. South Korea Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
- 7.4.6. Australia
- 7.4.6.1. Key Country Dynamics
- 7.4.6.2. Target Disease Prevalence
- 7.4.6.3. Competitive Scenario
- 7.4.6.4. Regulatory Framework
- 7.4.6.5. Reimbursement Scenario
- 7.4.6.6. Australia Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
- 7.4.7. Thailand
- 7.4.7.1. Key Country Dynamics
- 7.4.7.2. Target Disease Prevalence
- 7.4.7.3. Competitive Scenario
- 7.4.7.4. Regulatory Framework
- 7.4.7.5. Reimbursement Scenario
- 7.4.7.6. Thailand Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
- 7.5. Latin America
- 7.5.1. Latin America Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
- 7.5.2. Brazil
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Target Disease Prevalence
- 7.5.2.3. Competitive Scenario
- 7.5.2.4. Regulatory Framework
- 7.5.2.5. Reimbursement Scenario
- 7.5.2.6. Brazil Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
- 7.5.3. Mexico
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Target Disease Prevalence
- 7.5.3.3. Competitive Scenario
- 7.5.3.4. Regulatory Framework
- 7.5.3.5. Reimbursement Scenario
- 7.5.3.6. Mexico Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
- 7.5.4. Argentina
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Target Disease Prevalence
- 7.5.4.3. Competitive Scenario
- 7.5.4.4. Regulatory Framework
- 7.5.4.5. Reimbursement Scenario
- 7.5.4.6. Argentina Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
- 7.6. MEA
- 7.6.1. MEA Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
- 7.6.2. South Africa
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Target Disease Prevalence
- 7.6.2.3. Competitive Scenario
- 7.6.2.4. Regulatory Framework
- 7.6.2.5. Reimbursement Scenario
- 7.6.2.6. South Africa Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
- 7.6.3. Saudi Arabia
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Target Disease Prevalence
- 7.6.3.3. Competitive Scenario
- 7.6.3.4. Regulatory Framework
- 7.6.3.5. Reimbursement Scenario
- 7.6.3.6. Saudi Arabia Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
- 7.6.4. UAE
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Target Disease Prevalence
- 7.6.4.3. Competitive Scenario
- 7.6.4.4. Regulatory Framework
- 7.6.4.5. Reimbursement Scenario
- 7.6.4.6. UAE Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
- 7.6.5. Kuwait
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Target Disease Prevalence
- 7.6.5.3. Competitive Scenario
- 7.6.5.4. Regulatory Framework
- 7.6.5.5. Reimbursement Scenario
- 7.6.5.6. Kuwait Covid-19 Sample Collection Kits Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Company Categorization
- 8.2. Strategy Mapping
- 8.2.1. New Product Launch
- 8.2.2. Partnerships
- 8.2.3. Acquisition
- 8.2.4. Collaboration
- 8.2.5. Funding
- 8.3. Key Company Market Share Analysis, 2022
- 8.4. Company Profiles
- 8.4.1. Bd
- 8.4.1.1. Company Overview
- 8.4.1.2. Financial Performance
- 8.4.1.3. Product Benchmarking
- 8.4.1.4. Strategic Initiatives
- 8.4.2. Laboratory Corporation Of America Holdings
- 8.4.2.1. Company Overview
- 8.4.2.2. Financial Performance
- 8.4.2.3. Product Benchmarking
- 8.4.2.4. Strategic Initiatives
- 8.4.3. Copan Diagnostics, Inc
- 8.4.3.1. Company Overview
- 8.4.3.2. Financial Performance
- 8.4.3.3. Product Benchmarking
- 8.4.3.4. Strategic Initiatives
- 8.4.4. Puritan Medical Products
- 8.4.4.1. Company Overview
- 8.4.4.2. Product Benchmarking
- 8.4.4.3. Strategic Initiatives
- 8.4.5. Vitagene Inc.
- 8.4.5.1. Company Overview
- 8.4.5.2. Financial Performance
- 8.4.5.3. Product Benchmarking
- 8.4.5.4. Strategic Initiatives
- 8.4.6. Quest Diagnostics
- 8.4.6.1. Company Overview
- 8.4.6.2. Financial Performance
- 8.4.6.3. Product Benchmarking
- 8.4.6.4. Strategic Initiatives
- 8.4.7. Hardy Diagnostics
- 8.4.7.1. Company Overview
- 8.4.7.2. Financial Performance
- 8.4.7.3. Product Benchmarking
- 8.4.7.4. Strategic Initiatives
- 8.4.8. Danaher
- 8.4.8.1. Company Overview
- 8.4.8.2. Financial Performance
- 8.4.8.3. Product Benchmarking
- 8.4.8.4. Strategic Initiatives
- 8.4.9. Cepheid
- 8.4.9.1. Company Overview
- 8.4.9.2. Financial Performance
- 8.4.9.3. Product Benchmarking
- 8.4.9.4. Strategic Initiatives
- 8.4.10. Beckman Coulter, Inc.
- 8.4.10.1. Company Overview
- 8.4.10.2. Financial Performance
- 8.4.10.3. Product Benchmarking
- 8.4.10.4. Strategic Initiatives
- 8.4.11. Quidel Corporation
- 8.4.11.1. Company Overview
- 8.4.11.2. Financial Performance
- 8.4.11.3. Product Benchmarking
- 8.4.11.4. Strategic Initiatives
- 8.4.12. Thermo Fisher Scientific, Inc.
- 8.4.12.1. Company Overview
- 8.4.12.2. Financial Performance
- 8.4.12.3. Product Benchmarking
- 8.4.12.4. Strategic Initiatives
- 8.4.13. Trinity Biotech
- 8.4.13.1. Company Overview
- 8.4.13.2. Financial Performance
- 8.4.13.3. Product Benchmarking
- 8.4.13.4. Strategic Initiatives
- 8.4.14. Lucence Diagnostics Pte Ltd
- 8.4.14.1. Company Overview
- 8.4.14.2. Financial Performance
- 8.4.14.3. Product Benchmarking
- 8.4.14.4. Strategic Initiatives
- 8.4.15. Himedia Laboratories
- 8.4.15.1. Company Overview
- 8.4.15.2. Financial Performance
- 8.4.15.3. Product Benchmarking
- 8.4.15.4. Strategic Initiatives
- 8.4.16. Vircell S.L.
- 8.4.16.1. Company Overview
- 8.4.16.2. Financial Performance
- 8.4.16.3. Product Benchmarking
- 8.4.16.4. Strategic Initiatives
- 8.4.17. Formlabs
- 8.4.17.1. Company Overview
- 8.4.17.2. Financial Performance
- 8.4.17.3. Product Benchmarking
- 8.4.17.4. Strategic Initiatives